Literature DB >> 16613593

Kidney and pancreas transplantation in the United States, 1995-2004.

D J Cohen1, L St Martin, L L Christensen, R D Bloom, R S Sung.   

Abstract

This article examines OPTN/SRTR data on kidney and pancreas transplantation for 2004 and the previous decade, and discusses recent changes in kidney-pancreas (KP) allocation policy and emerging issues in kidney donation after cardiac death (DCD). Although the number of kidney donors continues to increase, new waiting list registrations again outpaced the number of kidney transplants performed, rising by 11% between 2003 and 2004 and contributing to a 1-year increase of 8% in the number of patients active on the waiting list. DCD has increased steadily since 2000; 39% more DCD transplants were performed in 2004 than 2003. Both deceased donor and living donor kidney graft survival rates remain excellent and are improving. The number of people living with a functioning kidney transplant doubled between 1995 and 2004, to 101,440 with a functioning kidney-alone and 7213 with a functioning KP. Health care providers in all settings are more likely to be exposed to these transplant recipients. Patient survival following simultaneous pancreas-kidney (SPK) transplantation is excellent and has improved incrementally since 1995; death rates in the first year fell from 60 per 1000 patient-years at risk in 2001 to 45 in 2003. The number of solitary pancreas transplants increased dramatically in 2004.

Entities:  

Mesh:

Year:  2006        PMID: 16613593     DOI: 10.1111/j.1600-6143.2006.01272.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  29 in total

1.  Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States.

Authors:  Jagbir Gill; Marcelo Sampaio; John S Gill; James Dong; Hung-Tien Kuo; Gabriel M Danovitch; Suphamai Bunnapradist
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent cytomegalovirus infection.

Authors:  K Welzl; B Weinberger; A Kronbichler; G Sturm; G Kern; G Mayer; B Grubeck-Loebenstein; C Koppelstaetter
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

3.  Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients.

Authors:  J R Cassuto; P P Reese; S Sonnad; R D Bloom; M H Levine; K M Olthoff; A Shaked; A Naji; P Abt
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

Review 4.  Islet transplantation and encapsulation: an update on recent developments.

Authors:  Vijayaganapathy Vaithilingam; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2011-05-10

5.  Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation.

Authors:  Jørn P Lindahl; Anders Hartmann; Svend Aakhus; Knut Endresen; Karsten Midtvedt; Hallvard Holdaas; Torbjørn Leivestad; Rune Horneland; Ole Øyen; Trond Jenssen
Journal:  Diabetologia       Date:  2015-12-28       Impact factor: 10.122

6.  Noninvasive allograft imaging of acute rejection: evaluation of (131)I-anti-CXCL10 mAb.

Authors:  Dayan Cheng; Hukui Sun; Ting Liang; Chao Zhang; Jing Song; Guihua Hou
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

7.  Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis.

Authors:  S Ansari; M B Bromberg; S B Gibson
Journal:  Clin Neurol Neurosurg       Date:  2017-07-05       Impact factor: 1.876

8.  Kidney organ donation: developing family practice initiatives to reverse inertia.

Authors:  Emmanouil K Symvoulakis; Emilia Stavroulaki; Myfanwy Morgan; Roger Jones
Journal:  BMC Health Serv Res       Date:  2010-05-17       Impact factor: 2.655

9.  Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.

Authors:  Jeong M Park; Kathleen D Lake; Diane M Cibrik
Journal:  Ther Drug Monit       Date:  2008-10       Impact factor: 3.681

10.  The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.

Authors:  Renaud Snanoudj; Carlos Frangié; Benjamin Deroure; Hélène François; Caroline Créput; Séverine Beaudreuil; Antoine Dürrbach; Bernard Charpentier
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.